- conflicts or gaps
- [[{"field": "founded_year", "conflict": {"value": "Tracxn lists founded 2015; company PR, Crunchbase, and LinkedIn list 2016 incorporation", "source_urls": ["https://tracxn.com/d/companies/darmiyan/__HIDN6cUfkYbOrcYCLP5r5_qGEeJKgNyODUVXhud5vTs", "https://www.prnewswire.com/news-releases/global-pharma-giant-eisai-leads-a-6m-series-seed-investment-round-in-darmiyan-to-expedite-its-clinical-market-entry-301038804.html", "https://www.crunchbase.com/organization/darmiyan"]}}, {"field": "headquarters", "conflict": {"value": "Most sources cite San Francisco HQ; CB Insights lists Berkeley; FDA De Novo lists Berkeley Way address", "source_urls": ["https://www.ycombinator.com/companies/darmiyan", "https://www.cbinsights.com/company/darmiyan", "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN220066"]}}, {"field": "total_funding", "conflict": {"value": "Total raised ranges from ~$10.0M to ~$14.7M depending on whether grants, non-equity assistance, and sub-round counting are included", "source_urls": ["https://www.cbinsights.com/company/darmiyan/financials", "https://tracxn.com/d/companies/darmiyan/__HIDN6cUfkYbOrcYCLP5r5_qGEeJKgNyODUVXhud5vTs", "https://www.ycdb.co/company/darmiyan", "https://www.linkedin.com/company/darmiyan"]}}, {"field": "latest_round_label", "conflict": {"value": "Oct 2023 ~$3.54M round labeled Series A (CB Insights), Seed (Company Check), or Venture–Series Unknown (VCBacked)", "source_urls": ["https://www.cbinsights.com/company/darmiyan/financials", "https://www.thecompanycheck.com/company/b/darmiyan/rjmrbmfa6mr3llxeu", "https://www.vcbacked.co/company/darmiyan"]}}, {"field": "employee_count", "conflict": {"value": "Headcount estimates vary: 8 (YC), 10 (YCDB), 15 (LinkedIn)", "source_urls": ["https://www.ycombinator.com/companies/darmiyan", "https://www.ycdb.co/company/darmiyan", "https://www.linkedin.com/company/darmiyan"]}}, {"field": "founders_on_yc_profile", "conflict": {"value": "YC lists only Padideh Kamali-Zare and Kaveh Vejdani as active founders; third co-founder Thomas Liebmann omitted from YC active founders list", "source_urls": ["https://www.ycombinator.com/companies/darmiyan", "https://tracxn.com/d/companies/darmiyan/__HIDN6cUfkYbOrcYCLP5r5_qGEeJKgNyODUVXhud5vTs", "https://darmiyan.com/team/"]}}, {"field": "eisai_round_announcement_date", "conflict": {"value": "Company blog post URL dated 2019-10-04 but headline says Mar 2020; official PR dated 2020-04-10", "source_urls": ["https://darmiyan.com/2019/10/04/pharma-giant-eisai-led-a-6m-round-in-darmiyan/", "https://www.prnewswire.com/news-releases/global-pharma-giant-eisai-leads-a-6m-series-seed-investment-round-in-darmiyan-to-expedite-its-clinical-market-entry-301038804.html"]}}, {"field": "revenue_valuation", "gap": {"value": "No verified public revenue or current post-2023 valuation disclosed in sourced materials", "source_urls": ["https://www.cbinsights.com/company/darmiyan/financials", "https://www.crunchbase.com/organization/darmiyan"]}}, {"field": "thomas_liebmann_current_involvement", "gap": {"value": "Role transitioned from CSO (ended Aug 2023) to Product Consultant; extent of day-to-day operational involvement unclear", "source_urls": ["https://darmiyan.com/thomas-liebmann/", "https://linkedin.com/in/tliebmann"]}}]]
- source urls
- ["https://brainsee.ai", "https://darmiyan.com/2019/10/04/pharma-giant-eisai-led-a-6m-round-in-darmiyan/", "https://darmiyan.com/2022/05/23/fda-breakthrough-designation-granted-to-brainsee/", "https://darmiyan.com/team/", "https://darmiyan.com/thomas-liebmann/", "https://linkedin.com/in/tliebmann", "https://tracxn.com/d/companies/darmiyan/__HIDN6cUfkYbOrcYCLP5r5_qGEeJKgNyODUVXhud5vTs", "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN220066", "https://www.cbinsights.com/company/darmiyan", "https://www.cbinsights.com/company/darmiyan/financials", "https://www.crunchbase.com/organization/darmiyan", "https://www.darmiyan.com", "https://www.fiercebiotech.com/medtech/fda-clears-ai-predicts-alzheimers-progression-mri-scan", "https://www.finsmes.com/2020/04/darmiyan-raises-6m-in-initial-close-of-seed-funding.html", "https://www.intelligence360.news/darmiyan-has-filed-a-notice-of-an-exempt-offering-of-securities-to-raise-3536249-00-in-new-equity-investment/", "https://www.linkedin.com/company/darmiyan", "https://www.prnewswire.com/news-releases/darmiyan-receives-fda-approval-for-brainsee-the-first-prognostic-test-for-predicting-likelihood-of-progression-to-alzheimers-dementia-302033616.html", "https://www.prnewswire.com/news-releases/darmiyan-receives-fda-approval-for-post-market-surveillance-study-of-brainsee-the-first-in-class-clinical-test-for-predicting-risk-of-progression-to-clinical-alzheimers-disease-302468072.html", "https://www.prnewswire.com/news-releases/global-pharma-giant-eisai-leads-a-6m-series-seed-investment-round-in-darmiyan-to-expedite-its-clinical-market-entry-301038804.html", "https://www.thecompanycheck.com/company/b/darmiyan/rjmrbmfa6mr3llxeu", "https://www.vcbacked.co/company/darmiyan", "https://www.ycdb.co/company/darmiyan", "https://www.ycombinator.com/companies/darmiyan"]